259 related articles for article (PubMed ID: 19297499)
1. Evidence that productive human immunodeficiency virus type 1 assembly can occur in an intracellular compartment.
Joshi A; Ablan SD; Soheilian F; Nagashima K; Freed EO
J Virol; 2009 Jun; 83(11):5375-87. PubMed ID: 19297499
[TBL] [Abstract][Full Text] [Related]
2. Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body.
Ono A; Freed EO
J Virol; 2004 Feb; 78(3):1552-63. PubMed ID: 14722309
[TBL] [Abstract][Full Text] [Related]
3. Elucidating the mechanism by which compensatory mutations rescue an HIV-1 matrix mutant defective for gag membrane targeting and envelope glycoprotein incorporation.
Tedbury PR; Mercredi PY; Gaines CR; Summers MF; Freed EO
J Mol Biol; 2015 Mar; 427(6 Pt B):1413-1427. PubMed ID: 25659909
[TBL] [Abstract][Full Text] [Related]
4. Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane.
Finzi A; Orthwein A; Mercier J; Cohen EA
J Virol; 2007 Jul; 81(14):7476-90. PubMed ID: 17507489
[TBL] [Abstract][Full Text] [Related]
5. Role of the human T-cell leukemia virus type 1 PTAP motif in Gag targeting and particle release.
Dorweiler IJ; Ruone SJ; Wang H; Burry RW; Mansky LM
J Virol; 2006 Apr; 80(7):3634-43. PubMed ID: 16537631
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
[TBL] [Abstract][Full Text] [Related]
7. Major histocompatibility complex class II molecules promote human immunodeficiency virus type 1 assembly and budding to late endosomal/multivesicular body compartments.
Finzi A; Brunet A; Xiao Y; Thibodeau J; Cohen EA
J Virol; 2006 Oct; 80(19):9789-97. PubMed ID: 16973583
[TBL] [Abstract][Full Text] [Related]
8. Inhibition or deficiency of cathepsin B leads defects in HIV-1 Gag pseudoparticle release in macrophages and HEK293T cells.
Ha SD; Park S; Hattlmann CJ; Barr SD; Kim SO
Antiviral Res; 2012 Jan; 93(1):175-84. PubMed ID: 22138708
[TBL] [Abstract][Full Text] [Related]
9. Real-time visualization of HIV-1 GAG trafficking in infected macrophages.
Gousset K; Ablan SD; Coren LV; Ono A; Soheilian F; Nagashima K; Ott DE; Freed EO
PLoS Pathog; 2008 Mar; 4(3):e1000015. PubMed ID: 18369466
[TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus type 1 assembly, budding, and cell-cell spread in T cells take place in tetraspanin-enriched plasma membrane domains.
Jolly C; Sattentau QJ
J Virol; 2007 Aug; 81(15):7873-84. PubMed ID: 17522207
[TBL] [Abstract][Full Text] [Related]
11. Virus particle release from glycosphingolipid-enriched microdomains is essential for dendritic cell-mediated capture and transfer of HIV-1 and henipavirus.
Akiyama H; Miller C; Patel HV; Hatch SC; Archer J; Ramirez NG; Gummuluru S
J Virol; 2014 Aug; 88(16):8813-25. PubMed ID: 24872578
[TBL] [Abstract][Full Text] [Related]
12. Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, gag-gag interactions, gag-membrane binding, and virion maturation.
Joshi A; Nagashima K; Freed EO
J Virol; 2006 Aug; 80(16):7939-51. PubMed ID: 16873251
[TBL] [Abstract][Full Text] [Related]
13. Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly.
Ono A; Orenstein JM; Freed EO
J Virol; 2000 Mar; 74(6):2855-66. PubMed ID: 10684302
[TBL] [Abstract][Full Text] [Related]
14. Molecular Determinants Directing HIV-1 Gag Assembly to Virus-Containing Compartments in Primary Macrophages.
Inlora J; Chukkapalli V; Bedi S; Ono A
J Virol; 2016 Oct; 90(19):8509-19. PubMed ID: 27440886
[TBL] [Abstract][Full Text] [Related]
15. Relationships between MA-RNA Binding in Cells and Suppression of HIV-1 Gag Mislocalization to Intracellular Membranes.
Thornhill D; Olety B; Ono A
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511376
[TBL] [Abstract][Full Text] [Related]
16. Virion-incorporated PSGL-1 and CD43 inhibit both cell-free infection and transinfection of HIV-1 by preventing virus-cell binding.
Murakami T; Carmona N; Ono A
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):8055-8063. PubMed ID: 32193343
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 Vpu inhibits accumulation of the envelope glycoprotein within clathrin-coated, Gag-containing endosomes.
Van Damme N; Guatelli J
Cell Microbiol; 2008 May; 10(5):1040-57. PubMed ID: 18076669
[TBL] [Abstract][Full Text] [Related]
18. GB virus type C E2 protein inhibits human immunodeficiency virus type 1 assembly through interference with HIV-1 gag plasma membrane targeting.
Timmons CL; Shao Q; Wang C; Liu L; Liu H; Dong X; Liu B
J Infect Dis; 2013 Apr; 207(7):1171-80. PubMed ID: 23303812
[TBL] [Abstract][Full Text] [Related]
19. A mutation in the human immunodeficiency virus type 1 Gag protein destabilizes the interaction of the envelope protein subunits gp120 and gp41.
Davis MR; Jiang J; Zhou J; Freed EO; Aiken C
J Virol; 2006 Mar; 80(5):2405-17. PubMed ID: 16474147
[TBL] [Abstract][Full Text] [Related]
20. The intracellular plasma membrane-connected compartment in the assembly of HIV-1 in human macrophages.
Nkwe DO; Pelchen-Matthews A; Burden JJ; Collinson LM; Marsh M
BMC Biol; 2016 Jun; 14():50. PubMed ID: 27338237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
